SL
BLFS icon

Salomon & Ludwin’s BioLife Solutions BLFS Stock Holding History

Salomon & Ludwin’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6K Buy
513
+472
+1,151% +$11K ﹤0.01% 1383
2026
Q1 		$800 Sell
41
-270
-87% -$5.97K ﹤0.01% 2019
2025
Q4 		$7.87K Sell
311
-44
-12% -$1.15K ﹤0.01% 1577
2025
Q3 		$9.44K Buy
+355
New +$8.42K ﹤0.01% 1348

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Salomon & Ludwin's BLFS Position: Q2 2026 in Review

Salomon & Ludwin increased its BioLife Solutions (BLFS) stake by 1,151% in Q2 2026, buying an estimated $11K and bringing the position to 513 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1383.

Salomon & Ludwin first reported a position in BLFS in Q3 2025 and has held it in 4 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Salomon & Ludwin held 513 shares of BioLife Solutions worth $14.6K as of Q2 2026.
  • Salomon & Ludwin bought 472 BioLife Solutions shares in Q2 2026, an estimated $11K.
  • BioLife Solutions made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1383 holding.
  • Salomon & Ludwin first reported a position in BioLife Solutions in Q3 2025 and has held it in 4 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.